Recent Updates
Recently added Catalysts
CHRS Positive Sentiment Score: 70/100

Coherus BioSciences Announces New Employment Inducement Grants

Tuesday, October 24, 2023 1 min read
Key Takeaway: Coherus BioSciences has granted options to purchase 64,500 shares of common stock to eight newly hired employees as part of its employment inducement strategy. The options were issued at a per share exercise price matching the closing trading price on the grant date, October 20, 2023. This initiative is designed to encourage talented professionals to join the company and aligns with its 2016 Employment Commencement Incentive Plan.

Market Sentiment Analysis

POSITIVE FACTORS

  • Coherus BioSciences is expanding its workforce with new employees.
  • The grants may help attract skilled professionals to the company.
  • The stock options are tied to the company's performance, suggesting alignment of interests.

Full Press Release Details

REDWOOD CITY, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective October 20, 2023, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 64,500 shares of the common stock of the Company to eight newly hired employees with a per share exercise price of $3.54, the closing trading price on the grant date.
The stock options were granted pursuant to the Coherus BioSciences, Inc. 2016 Employment Commencement Incentive Plan, which was approved by the Company’s board of directors in June 2016 under Rule 5635(c)(4) of the Nasdaq Global Select Market for equity grants to induce new employees to enter into employment with the Company.
Coherus BioSciences Contact Information:
Coherus BioSciences, Inc.

Frequently Asked Questions

When were stock options granted by Coherus BioSciences?

Stock options were granted on October 20, 2023.

How many shares were granted in total?

A total of 64,500 shares were granted as stock options.

What was the exercise price for the stock options?

The exercise price was set at $3.54 per share.

What plan facilitated the stock option grants?

The stock options were granted under the 2016 Employment Commencement Incentive Plan.

Who received the stock options from Coherus?

The stock options were granted to eight newly hired employees.

Tags: CHRS Viatris Investor Conferences Healthcare Coherus BioSciences employment inducement stock options equity grants
Last updated: Oct 24, 2023